Your browser is no longer supported. Please, upgrade your browser.
Settings
CRL Charles River Laboratories International, Inc. daily Stock Chart
CRL [NYSE]
Charles River Laboratories International, Inc.
Index- P/E22.27 EPS (ttm)3.06 Insider Own0.30% Shs Outstand46.62M Perf Week-5.79%
Market Cap3.18B Forward P/E16.39 EPS next Y4.16 Insider Trans-28.72% Shs Float45.81M Perf Month-13.67%
Income145.50M PEG2.37 EPS next Q0.94 Inst Own- Short Float3.38% Perf Quarter-7.90%
Sales1.34B P/S2.37 EPS this Y25.60% Inst Trans1.45% Short Ratio2.96 Perf Half Y-9.00%
Book/sh15.22 P/B4.48 EPS next Y12.01% ROA7.60% Target Price83.12 Perf Year-0.93%
Cash/sh1.97 P/C34.54 EPS next 5Y9.42% ROE21.10% 52W Range59.99 - 84.69 Perf YTD-15.21%
Dividend- P/FCF14.32 EPS past 5Y9.40% ROI9.00% 52W High-19.52% Beta1.34
Dividend %- Quick Ratio1.50 Sales past 5Y2.10% Gross Margin38.10% 52W Low13.62% ATR2.97
Employees7900 Current Ratio1.80 Sales Q/Q6.70% Oper. Margin14.60% RSI (14)34.57 Volatility4.61% 4.21%
OptionableYes Debt/Eq1.21 EPS Q/Q16.20% Profit Margin10.80% Rel Volume1.88 Prev Close67.10
ShortableYes LT Debt/Eq1.19 EarningsFeb 10 BMO Payout0.00% Avg Volume523.78K Price68.16
Recom2.40 SMA20-7.89% SMA50-10.70% SMA200-5.91% Volume983,649 Change1.58%
Jan-07-16Upgrade Wells Fargo Market Perform → Outperform
Oct-12-15Upgrade Wells Fargo Underperform → Market Perform
Jul-31-15Reiterated Deutsche Bank Hold $76 → $79
Jul-10-15Upgrade BofA/Merrill Neutral → Buy $76 → $83
Jul-10-15Downgrade Barclays Equal Weight → Underweight $60
May-04-15Upgrade Sun Trust Rbsn Humphrey Neutral → Buy $88
Apr-24-15Reiterated Barclays Equal Weight $55 → $60
Feb-12-15Reiterated Deutsche Bank Hold $63 → $77
Feb-13-14Reiterated Barclays Equal Weight $41 → $55
Nov-21-13Initiated Deutsche Bank Hold $55
Sep-17-13Initiated UBS Neutral $49
Jun-03-13Reiterated Barclays Equal Weight $38 → $41
May-02-13Reiterated ISI Group Neutral $45.50 → $44.50
Feb-14-13Reiterated ISI Group Neutral $40.50 → $43
Jul-14-11Initiated BB&T Capital Mkts Buy $47
May-05-11Reiterated UBS Neutral $40 → $42
Jan-06-11Downgrade Deutsche Bank Buy → Hold $37 → $37
May-12-10Upgrade Robert W. Baird Neutral → Outperform $37
Jan-07-10Upgrade Deutsche Bank Hold → Buy $38.50 → $39
Nov-09-09Downgrade Barclays Capital Overweight → Equal Weight
Jan-27-16 02:03PM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : January 27, 2016
08:04AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : January 27, 2016
Jan-22-16 09:30AM  Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
Jan-20-16 04:30PM  Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings and 2016 Guidance Release and Conference Call Business Wire
Jan-19-16 09:30AM  New Strong Buy Stocks for January 19th
06:04AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in
Jan-13-16 08:01AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : January 13, 2016
Jan-09-16 06:00AM  Jim Cramer's Top Takeaways: Charles River Labs, Wells Fargo, Citigroup, PNC at TheStreet
Jan-08-16 04:31PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulati
Jan-07-16 05:24PM  Charles River Laboratories Int'l, Inc. -- Moody's affirms Charles River's Ba2 CFR; outlook to stable at Moody's
09:28AM  Charles River upgraded by Wells Fargo
06:30AM  Charles River Laboratories to Acquire WIL Research Business Wire
Dec-28-15 04:56PM  INC Research Holdings Aims For Top Five CRO Status at Investor's Business Daily
Dec-27-15 09:21PM  WEEKEND VIDEO: An Important Technical Level for the Market
01:33PM  5 Trade ideas for Monday: Agilent, BorgWarner, Charles River Labs, Intercontinental Exchange and Priogressive
Dec-14-15 07:16PM  Here is What Hedge Funds Think About Cognex Corporation (CGNX) at Insider Monkey
Dec-10-15 06:06AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-08-15 01:17PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials
08:30AM  Charles River Laboratories Expands Long-Standing Collaboration with The Michael J. Fox Foundation for Parkinsons Research Business Wire
Dec-01-15 03:24PM  Express Scripts/Imprimis to Offer Cheaper Daraprim Version
Nov-29-15 03:58AM  Here is What Hedge Funds Think About Charles River Laboratories (CRL) at Insider Monkey
Nov-26-15 04:13AM  Is Controladora Vuela Co Avcn SA CV (ADR) (VLRS) A Good Stock To Buy? at Insider Monkey
Nov-20-15 11:55AM  Why Charles River Labs spent $36M on a German drug testing business at bizjournals.com
Nov-18-15 04:15PM  Charles River Laboratories Acquires Oncotest GmbH Business Wire
10:51AM  Charles River Laboratories International, Inc. Earnings Q3, 2015
Nov-17-15 08:30AM  Regen BioPharma Inc. Submits Response to FDA Questions on HemaXellerate Investigational New Drug Application PR Newswire
Nov-16-15 01:46PM  The Best Healthcare Stock Ideas Of HealthInvest Partners AB at Insider Monkey
Nov-04-15 03:10PM  Edited Transcript of CRL earnings conference call or presentation 4-Nov-15 1:30pm GMT
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
08:01AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:21AM  Charles River tops Street 3Q forecasts
07:07AM  Q3 2015 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:00AM  Charles River Laboratories Announces Third-Quarter 2015 Results from Continuing Operations Business Wire
Oct-29-15 02:10PM  McKesson (MCK) Beats on Earnings in Q2, Upgrades View
09:02AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : October 29, 2015
Oct-27-15 01:25PM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : October 27, 2015
Oct-23-15 02:01PM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : October 23, 2015
Oct-19-15 08:30AM  Charles River Laboratories Presents 25 Scientific Posters at Neuroscience 2015 Business Wire
Oct-12-15 08:42AM  Analysts' Actions -- Baidu, EMC, Exxon Mobil, NetApp and More
Oct-08-15 04:30PM  Charles River Laboratories Schedules Third-Quarter 2015 Earnings Release and Conference Call Business Wire
Oct-07-15 08:30AM  Charles River Announces New and Continued Drug Discovery Collaborations Business Wire
Sep-18-15 02:14PM  ETFs with exposure to Charles River Laboratories International, Inc. : September 18, 2015
10:53AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : September 18, 2015
Sep-15-15 08:30AM  Charles River Laboratories to Present at Morgan Stanley Conference Business Wire
Sep-08-15 04:33PM  Four Value Stocks to Consider in a Tough Market at TheStreet
Sep-03-15 09:25AM  BioTelemetry (BEAT) Worth Watching: Stock Rises 6.7%
Aug-28-15 01:55PM  Charles River Laboratories International, Inc. Earnings Q2, 2015
Aug-18-15 04:45PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
Aug-16-15 09:10AM  Credit Suisse Sees Big Biopharma Upside in Top Contract Research Outfits at 24/7 Wall St.
Aug-12-15 06:00AM  Jim Cramer's Top Takeaways: WisdomTree Investments, Google, Charles River Labs at TheStreet
Aug-11-15 08:08PM  Jim Cramer's 'Mad Money' Recap: How to Make Sense of China's Desperate Act at TheStreet
Aug-10-15 09:30AM  Zacks Investment Ideas feature highlights: INC Research, AMN Healthcare Services, Charles River Associates, Envision Healthcare and Express Scripts - Press Releases
Aug-05-15 08:53AM  How Charles River Laboratories International (CRL) Stock Stands Out in a Strong Industry - Tale of the Tape
Aug-04-15 10:40AM  Intertek Group Plc: Strong price momentum but will it sustain?
Aug-01-15 08:09PM  10-Q for Charles River Laboratories International, Inc. at Company Spotlight
Jul-30-15 04:21PM  Edited Transcript of CRL earnings conference call or presentation 30-Jul-15 12:30pm GMT
09:06AM  McKesson (MCK) Tops Q1 Earnings, Ups Fiscal '16 Outlook - Analyst Blog
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
08:13AM  Charles River misses 2Q profit forecasts
07:15AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:07AM  Q2 2015 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:01AM  Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement Business Wire
07:00AM  Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing Operations Business Wire
Jul-24-15 04:05PM  Charles River Laboratories Completes the Acquisition of Celsis International Ltd. Business Wire
Jul-21-15 02:15PM  Its earnings season: Here are 9 local biotech firms that are actually making a profit at bizjournals.com
Jul-17-15 09:05AM  Huge Biotech Index Rebalance Means Massive Buy Orders for 5 Stocks at 24/7 Wall St.
Jul-10-15 12:21PM  Charles River Laboratories (CRL) Stock Downgraded at Barclays at TheStreet
08:15AM  Analysts' Actions -- Ameriprise, Costco, Nokia and More
08:11AM  Barclays Cuts Charles River Labs, Sees Lack Of Demand Proof Over Long-Term
Jul-09-15 08:25PM  Carl Announces Completion of Private Placement Marketwired
02:01PM  Why Charles River Labs spent $212M on a bacteria detection company at bizjournals.com
07:00AM  Charles River Laboratories to Acquire Celsis International Ltd. Business Wire
Jul-07-15 09:09PM  Carl Announces Private Placement Marketwired
04:15PM  Charles River Laboratories Schedules Second-Quarter 2015 Earnings Release and Conference Call Business Wire
07:00AM  4 Stocks Rising on Unusual Volume at TheStreet
Jun-18-15 09:00AM  Carl Subsidary Signs Data Services Agreement With RA Revenue Automation Marketwired
Jun-02-15 09:10AM  Analyst Offers Top US Growth Stock Calls for This Week at 24/7 Wall St.
Jun-01-15 08:00AM  Charles River Laboratories to Present at Jefferies Conference Business Wire
May-27-15 11:59AM  Jefferies Boosts Targets Across Pharmaceutical Service Stocks
May-26-15 09:00AM  Carl Appoints Industry Expert Bryan Segal to the Board of Directors Marketwired
May-11-15 11:50AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
May-04-15 08:12PM  10-Q for Charles River Laboratories International, Inc. at Company Spotlight
04:54PM  Charles River Laboratories to Present at Baird and Deutsche Bank Conferences at noodls
04:30PM  Charles River Laboratories to Present at Baird and Deutsche Bank Conferences Business Wire
Apr-30-15 09:00AM  Charles River Laboratories International Inc Earnings Call scheduled for 9:00 am ET today -9.30%
06:10AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
Apr-29-15 05:17PM  Charles River Laboratories Announces First-Quarter 2015 Results from Continuing Operations at noodls
04:39PM  Charles River misses Street 1Q forecasts
04:30PM  Charles River Laboratories Announces First-Quarter 2015 Results from Continuing Operations Business Wire
07:07AM  Q1 2015 Charles River Laboratories International Inc Earnings Release - After Market Close
Apr-27-15 06:03PM  Charles River Laboratories Int'l, Inc. -- Moody's affirms Charles River's Ba2 CFR; changes outlook to positive at Moody's
09:02AM  Jefferies Previews Booming Biotech Earnings
Apr-22-15 04:31PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obli
Apr-16-15 09:00AM  Carl Enters Into Letter of Intent for the Purchase of FlowWorks Inc. Marketwired
Apr-09-15 09:32AM  Charles River Laboratories Schedules First-Quarter 2015 Earnings Release and Conference Call at noodls
09:00AM  Charles River Laboratories Schedules First-Quarter 2015 Earnings Release and Conference Call Business Wire
Mar-26-15 08:25AM  Top Analyst Upgrades and Downgrades: Apple, ASML, Schwab, GoPro, Kraft, Netflix, Red Hat and More at 24/7 Wall St.
Mar-11-15 04:06PM  Teachers adds a new stake in PRA Health Sciences
Mar-09-15 07:31PM  Charles River Laboratories to Present at March Investor Conferences at noodls
Mar-02-15 08:00AM  Charles River Laboratories to Present at March Investor Conferences Business Wire
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and preclinical development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist its clients in supporting the use of research models in drug discovery and development comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target within a cell through delivery of clinical drug candidates; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides non-animal or in vitro methods for lot release testing of medical devices and injectable drugs for endotoxin contamination. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and specific pathogen free fertile chicken eggs and chickens for the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHUBB STEPHEN DDirectorFeb 01Sale74.762,000149,52311,504Feb 03 09:38 AM
ACKERMAN THOMAS FSenior Financial AdvisorDec 17Option Exercise37.0310,000370,300110,635Dec 18 01:57 PM
MASSARO GEORGEDirectorDec 17Option Exercise40.277,740311,69020,860Dec 18 02:08 PM
MASSARO GEORGEDirectorDec 17Sale80.007,740619,20013,120Dec 18 02:08 PM
ACKERMAN THOMAS FSenior Financial AdvisorDec 17Sale80.0010,000800,000100,635Dec 18 01:57 PM
ACKERMAN THOMAS FSenior Financial AdvisorNov 19Option Exercise37.0310,000370,300110,635Nov 20 12:57 PM
ACKERMAN THOMAS FSenior Financial AdvisorNov 19Sale75.0010,000750,000100,635Nov 20 12:57 PM
ACKERMAN THOMAS FSenior Financial AdvisorNov 04Option Exercise36.7921,612795,135122,247Nov 06 10:04 AM
ACKERMAN THOMAS FSenior Financial AdvisorNov 04Sale70.0121,6121,512,971100,635Nov 06 10:04 AM
ACKERMAN THOMAS FSenior Financial AdvisorAug 17Option Exercise37.925,000189,600105,635Aug 18 02:09 PM
ACKERMAN THOMAS FSenior Financial AdvisorAug 17Sale75.535,000377,665100,635Aug 18 02:09 PM
Kochevar Deborah TurnerDirectorAug 03Option Exercise52.293,530184,58414,270Aug 05 08:57 AM
CHUBB STEPHEN DDirectorAug 03Sale76.462,000152,92715,504Aug 05 07:31 AM
Kochevar Deborah TurnerDirectorAug 03Sale76.696,250479,3048,020Aug 05 08:57 AM
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Option Exercise37.925,000189,600105,635May 18 04:11 PM
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Sale71.061,10078,168100,635May 18 04:13 PM
ACKERMAN THOMAS FCorporate Executive VP & CFOMay 15Sale70.513,900274,974101,735May 18 04:11 PM
MASSARO GEORGEDirectorMay 07Sale70.211,36095,48715,120May 08 07:26 AM
CHUBB STEPHEN DDirectorMay 01Sale69.802,000139,59515,534May 05 04:48 PM
Crowley John JSVP, Chief Accounting OfficerMar 04Option Exercise59.4191254,1826,131Mar 06 12:50 PM
Crowley John JSVP, Chief Accounting OfficerMar 04Sale76.5391269,7925,219Mar 06 12:50 PM
CHUBB STEPHEN DDirectorMar 03Sale75.522,000151,04717,854Mar 05 08:17 AM
FOSTER JAMES CChairman, President and CEOMar 02Option Exercise59.4120,0711,192,418360,333Mar 04 06:34 AM
GILLETT NANCYCorporate Executive VPMar 02Option Exercise59.414,379260,15622,589Mar 03 02:42 PM
Kochevar Deborah TurnerDirectorMar 02Sale76.592,600199,1378,770Mar 03 02:59 PM
GILLETT NANCYCorporate Executive VPMar 02Sale76.724,379335,94918,210Mar 03 02:42 PM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.932,036156,625340,262Mar 04 06:39 AM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.679,483727,051342,298Mar 04 06:36 AM
FOSTER JAMES CChairman, President and CEOMar 02Sale76.488,552654,091351,781Mar 04 06:34 AM
GILLETT NANCYCorporate Executive VPFeb 27Sale76.952,772213,30619,162Mar 03 11:31 AM
GELLER JORGCorporate Executive VPFeb 25Option Exercise37.032,863106,01717,820Feb 27 09:33 AM
GILLETT NANCYCorporate Executive VPFeb 25Option Exercise37.8417,477661,39639,411Feb 27 09:55 AM
FOSTER JAMES CChairman, President and CEOFeb 25Option Exercise37.0335,5381,315,972360,083Feb 27 09:41 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.273,532269,39922,805Feb 26 12:06 PM
GELLER JORGCorporate Executive VPFeb 25Sale76.793,726286,12614,094Feb 27 09:33 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.8611,003845,683324,545Feb 27 09:53 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.7112,914990,641335,548Feb 27 09:51 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale76.457,000535,142348,462Feb 27 09:44 AM
FOSTER JAMES CChairman, President and CEOFeb 25Sale75.964,621351,029355,462Feb 27 09:41 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.8011,477881,47621,934Feb 27 09:57 AM
GILLETT NANCYCorporate Executive VPFeb 25Sale76.596,000459,53833,411Feb 27 09:55 AM
FOSTER JAMES CChairman, President and CEOFeb 24Option Exercise36.2524,387884,029364,482Feb 25 05:24 PM
GELLER JORGCorporate Executive VPFeb 24Option Exercise36.256,987253,27928,319Feb 25 09:34 PM
GILLETT NANCYCorporate Executive VPFeb 24Sale75.741,483112,32727,969Feb 26 12:06 PM
GELLER JORGCorporate Executive VPFeb 24Sale76.301,30199,26014,957Feb 25 09:39 PM
GELLER JORGCorporate Executive VPFeb 24Sale76.1712,061918,65615,558Feb 25 09:34 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale76.2212,433947,582342,178Feb 25 05:28 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale76.402,083159,145340,095Feb 25 05:29 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale75.704,800363,364359,682Feb 25 05:24 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale75.965,071385,217354,611Feb 25 05:26 PM
FOSTER JAMES CChairman, President and CEOFeb 23Option Exercise40.4021,779879,872361,874Feb 25 09:23 AM
GELLER JORGCorporate Executive VPFeb 23Option Exercise40.405,502222,28128,373Feb 24 02:22 PM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.973,400261,684340,095Feb 25 09:29 AM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.769,956764,174343,495Feb 25 09:26 AM
FOSTER JAMES CChairman, President and CEOFeb 23Sale76.568,423644,829353,451Feb 25 09:23 AM
GELLER JORGCorporate Executive VPFeb 23Sale76.597,041539,29121,332Feb 24 02:22 PM
MILNE GEORGE M JRDirectorFeb 20Option Exercise61.726,000370,32036,790Feb 23 01:00 PM
FOSTER JAMES CChairman, President and CEOFeb 20Option Exercise58.5870,2294,114,015413,193Feb 24 04:01 PM
FOSTER JAMES CChairman, President and CEOFeb 20Sale75.0070,2295,267,175342,964Feb 24 04:01 PM
MILNE GEORGE M JRDirectorFeb 20Sale75.876,000455,22330,790Feb 23 01:00 PM
FOSTER JAMES CChairman, President and CEOFeb 19Option Exercise58.589,671566,527352,635Feb 20 01:29 PM
FOSTER JAMES CChairman, President and CEOFeb 19Sale75.009,671725,325342,964Feb 20 01:29 PM
CHUBB STEPHEN DDirectorFeb 18Option Exercise61.726,000370,32024,865Feb 19 07:22 AM
CHUBB STEPHEN DDirectorFeb 18Sale73.975,011370,64919,854Feb 19 07:22 AM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Option Exercise36.925,000184,600109,211Feb 18 02:12 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Sale73.7560044,248104,211Feb 18 02:14 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOFeb 17Sale73.504,400323,398104,811Feb 18 02:12 PM
GELLER JORGCorporate Executive VPFeb 17Sale73.722,570189,46922,871Feb 18 01:11 PM
GELLER JORGCorporate Executive VPFeb 17Sale73.5414,4301,061,12025,441Feb 18 01:09 PM
Molho DavideCorporate Executive VPFeb 13Option Exercise36.252,40087,00045,704Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 13Sale74.0058243,068574Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 13Sale74.002,400177,60043,304Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 12Option Exercise36.258,675314,46951,979Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 12Sale74.007,418548,9321,156Feb 17 10:05 AM
Molho DavideCorporate Executive VPFeb 12Sale74.008,675641,95043,304Feb 17 10:05 AM
GELLER JORGCorporate Executive VPFeb 12Sale73.688,458623,16339,871Feb 17 07:59 AM